Tata Elxsi Share Price in Focus After Release of Q4FY25 Earnings: Revenue and PAT Declined QoQ

On April 21, 2025, Tata Elxsi share price is on investors’ radar as the company released its results for the quarter (Q4FY25) and year (FY25) ended March 31, 2025. During the period, the company recorded mixed performance during the period.

Tata Elxsi Q4FY25 Performance

For the quarter ended March 31, 2025, the company reported operating revenue of ₹908.3 crore, a slump of 3.3% QoQ, while growth of 0.3% YoY. The company reported an EBITDA margin of 22.9% and a Profit Before Tax (PBT) margin of 23.3%. PBT stood at ₹221.4 crore, reflecting a decline of 15.6% year-on-year and 13.4% quarter-on-quarter. Net Profit (PAT) came in at ₹172.4 crore, down 12.4% compared to the same period last year and 13.4% lower than the previous quarter.

Tata Elxsi Segmental Overview

The Transportation segment saw a 9.7% QoQ decline in constant currency (CC) terms, primarily due to project pauses with certain clients during the quarter. Media and Communications revenue also fell, down 6.3% QoQ in CC terms, reflecting ongoing industry softness and conservative technology spending. In contrast, the Healthcare segment posted a 3.5% QoQ growth in CC terms, driven by new customer acquisitions and increasing momentum from digital and Gen AI-powered solutions.

Tata Elxsi Dividend

The Board of Tata Elxsi have recommended a final dividend of 750% (₹75 per equity share of par value of ₹10 each) for FY25, subject to approval by the shareholders.

Significant Deals During FY25

Tata Elxsi secured several significant deals during the quarter, underscoring its strategic growth and technological leadership across verticals. The company won a landmark multi-year consolidation deal worth over US$100 million from a leading Media & Communications firm to drive next-generation product engineering across its video and broadband portfolio.

In the automotive space, Tata Elxsi signed a strategic €50 million multi-year agreement with a prominent European automotive OEM to deliver platform and application development for Software-Defined Vehicles (SDVs), electrification, and body and chassis systems.

In healthcare, the company was awarded a large contract by a leading European Renal care Medtech player to enhance software functionality, cybersecurity, interoperability, and lifecycle management for their critical care devices.

Additionally, Tata Elxsi won a strategic US$10 million consolidation deal with a global broadcaster to support engineering for their streaming video platform. The company also secured a multi-million-dollar digital design deal to develop an advanced fleet management software solution for electric vehicles, leveraging next-generation analytics and AI technologies.

Also Read: Tata Elxsi Share Price in Focus in Anticipation of FY25 Dividend Declaration

Conclusion

Tata Elxsi FY25 results showcased a subdued picture as the company witnessed a fall in top line and bottom line on a sequential basis, while growth in FY25.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.